Background Bronchopulmonary dysplasia (BPD) is the result of a complex process in which
several prenatal and/or postnatal factors interfere with lower respiratory tract development …

Bronchopulmonary dysplasia (BPD) is potentially one of the most devastating conditions in
premature infants with longstanding consequences involving multiple organ systems …

Pulmonary hypertension is associated with diverse cardiac, pulmonary, and systemic
diseases in neonates, infants, and older children and contributes to significant morbidity and …

Nitric oxide (NO) signaling plays a major role in modulating vascular tone and remodeling in
the pulmonary circulation, but its role in the pathogenesis of pulmonary vascular diseases is …

BACKGROUND: The use of unnecessary tests and treatments contributes to health care
waste. The “Choosing Wisely” campaign charges medical societies with identifying such …

Preterm birth is a significant public health concern, as it is associated with high risk of infant
mortality, various morbidities in both the neonatal period and later in life, and a significant …

Nitric oxide, an important signaling molecule with multiple regulatory effects throughout the
body, is an important tool for the treatment of full-term and late-preterm infants with persistent …

Neonatal chronic lung disease, also known as bronchopulmonary dysplasia (BPD), is the
most common complication of premature birth, affecting up to 30% of very low birth weight …

Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …

In 1967, Northway and colleagues 1 described bronchopulmonary dysplasia (BPD) as a
lung condition of prematurity that began with diffuse parenchymal lung disease and a …